Mallinckrodt Pharmaceuticals was recently named the 2018 Science Leadership Award recipient by the Academy of Science in St. Louis, Missouri. The award is presented annually to distinguished individuals or organizations who have made important contributions […]
In partnership with the New Jersey Department of Transportation and the New Jersey Clean Communities Council, Mallinckrodt has entered into a two-year agreement to clean the one-mile stretch of U.S. Route 206, which runs along […]
On February 13, 2018, Mallinckrodt Pharmaceuticals acquired Sucampo Pharmaceuticals, including VTS-270, an investigational treatment for a devastating, rare neurodegenerative and ultimately fatal disease called Niemann-Pick disease type C1 (NPC). NPC is an inherited lysosomal storage […]
House Minority Whip Steny Hoyer (D-MD) and Congressman Mark Pocan (D-WI) recently received a hands-on tour of Mallinckrodt’s Madison, Wis. regenerative medicine site, where they learned about the company’s innovative work happening there. The Mallinckrodt […]